Evolution of the Average Target: Nuvei Corporation

Evolution of the Target Price: Nuvei Corporation

Changes in Analyst Recommendations: Nuvei Corporation

b07b67fe6b5b.q3to-FqmGo0vEpypLnmQX8vLCCl8cT7TvHiYxxe0EVA.-g0j1WLHQLwaJP_ZYjPxFYD-XWouOU2bzh_PiXbdSyKaKhrIHf9e-EFI9w~125f40867f853dcc62e6a841e298c74b
Nuvei Brief: Proxy Advisor ISS Recommends Nuvei Shareholders Vote "FOR" Arrangement in Advance of the June 14, 2024 MT
Nuvei Brief: Board recommends shareholders vote "FOR" the Arrangement MT
JPMorgan Downgrades Nuvei to Neutral From Overweight, Raises Price Target to $34 From $32 MT
UBS on Nuvei Going Private Transaction MT
Citigroup Raises Nuvei's Price Target to $34 From $23, Maintains Neutral Rating MT
UBS Downgrades Nuvei to Neutral From Buy, Raises Price Target to $34 From $30 MT
Keefe Bruyette & Woods Downgrades Nuvei to Market Perform From Outperform, Adjusts PT to $34 From $31 MT
Seaport Global Downgrades Nuvei to Neutral From Buy MT
Wolfe Research Downgrades Nuvei to Peer Perform From Outperform MT
William Blair Downgrades Nuvei to Market Perform From Outperform MT
Barclays Adjusts Price Target on Nuvei to $32 From $34, Maintains Overweight Rating MT
UBS Raises Nuvei Price Target to $30 From $24, Maintains Buy Rating MT
Wells Fargo Adjusts Price Target on Nuvei to $27 From $29, Maintains Equalweight Rating MT
RBC Raises Price Target on Nuvei to $34 From $29, Keeps Outperform Rating MT
Wells Fargo Starts Nuvei With Equalweight Rating, $29 Price Target MT
Goldman Sachs Adjusts Price Target on Nuvei to $30 From $21, Maintains Neutral Rating MT
Barclays Initiates Nuvei at Overweight Rating With $34 Price Target MT
Nuvei Maintained at Outperform at BMO Following Analyst Switch; Price Target Kept at US$30.00 MT
Seaport Initiates Nuvei at Buy With $25 Price Target, Cites 'Intriguing Growth Profile at Reasonable Valuation' MT
Goldman Sachs Adjusts Nuvei's Price Target to $21 From $19, Maintains Neutral Rating MT
UBS Adjusts Nuvei Price Target to $24 From $20, Maintains Buy Rating MT
UBS Initiates Coverage on Nuvei With Buy Rating, $20 Price Target MT
Raymond James Trims Price Target on Nuvei to $27 From $28, Maintains Outperform Rating MT
Goldman Sachs Adjusts Price Target on Nuvei to $19 From $22, Maintains Neutral Rating MT
Goldman Sachs Adjusts Nuvei Price Target to $19 From $22, Maintains Neutral Rating MT
More recommendations

Add to a list
Analyst Opinion 4m Revision of opinion Divergence of analysts' opinions Divergence of Target Price Ecart obj. / dr
+3.94%
+10.44%
+30.18%
+35.90%
+43.55%
+12.31%
+21.14%
+40.98%
+27.57%
+28.52%
Average +25.45%
Weighted average by Cap. +23.83%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
11
Last Close Price
33.01USD
Average target price
34.31USD
Spread / Average Target
+3.94%
High Price Target
34.62USD
Spread / Highest target
+4.87%
Low Price Target
34.00USD
Spread / Lowest Target
+3.01%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

JPMorgan Chase
Citigroup
UBS
Keefe, Bruyette & Woods
Seaport Global Securities
Wolfe Research
William Blair & Co.
Barclays
Wells Fargo Securities
RBC Capital Markets
Goldman Sachs
BMO Capital
Raymond James
Canaccord Genuity
Credit Suisse
SMBC Nikko
WestPark Capital
Trading Rating
Investor Rating
ESG Refinitiv
D-
More Ratings
  1. Stock Market
  2. Equities
  3. NVEI Stock
  4. Consensus Nuvei Corporation